Financial Summary (All financials)
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
Revenues | 29,310.0 | 24,105.0 | 21,846.0 | 22,977.0 | 20,609.0 | 18,358.0 | 15,082.0 | 13,880.0 |
Revenue growth | 21.6% | 10.3% | -4.9% | 11.5% | 12.3% | 21.7% | 8.7% | 9.3% |
Cost of goods sold | 4,990.0 | 4,240.0 | 3,785.0 | 3,444.0 | 3,170.0 | 2,628.0 | 2,226.0 | 2,079.0 |
Gross profit | 24,320.0 | 19,865.0 | 18,061.0 | 19,533.0 | 17,439.0 | 15,730.0 | 12,856.0 | 11,801.0 |
Gross margin | 83.0% | 82.4% | 82.7% | 85.0% | 84.6% | 85.7% | 85.2% | 85.0% |
Sales and marketing | 1,336.0 | 1,136.0 | 971.0 | 1,105.0 | 988.0 | 922.0 | 869.0 | 872.0 |
Research and development | 743.0 | 730.0 | 727.0 | 721.0 | 686.0 | 620.0 | 538.0 | 474.0 |
General and administrative | 1,699.0 | 1,388.0 | 1,504.0 | 1,650.0 | 1,591.0 | 1,469.0 | 1,185.0 | 883.0 |
EBITA | 19,736.0 | 15,890.0 | 14,172.0 | 15,461.0 | 13,616.0 | 12,219.0 | 9,812.0 | 9,141.0 |
EBITA margin | 67.3% | 65.9% | 64.9% | 67.3% | 66.1% | 66.6% | 65.1% | 65.9% |
Amortization of intangibles | 90.0 | 83.0 | 80.0 | 60.0 | 55.0 | 56.0 | 50.0 | 63.0 |
EBIT | 19,646.0 | 15,807.0 | 14,092.0 | 15,401.0 | 13,561.0 | 12,163.0 | 9,762.0 | 9,078.0 |
EBIT margin | 67.0% | 65.6% | 64.5% | 67.0% | 65.8% | 66.3% | 64.7% | 65.4% |
Pre-tax income | 18,136.0 | 16,063.0 | 13,790.0 | 14,884.0 | 12,806.0 | 11,694.0 | 8,012.0 | 8,995.0 |
Income taxes | 3,179.0 | 3,752.0 | 2,924.0 | 2,804.0 | 2,505.0 | 4,995.0 | 2,021.0 | 2,667.0 |
Tax rate | 17.5% | 23.4% | 21.2% | 18.8% | 19.6% | 42.7% | 25.2% | 29.6% |
Net income | 14,957.0 | 12,311.0 | 10,866.0 | 12,080.0 | 10,301.0 | 6,699.0 | 5,991.0 | 6,328.0 |
Net margin | 51.0% | 51.1% | 49.7% | 52.6% | 50.0% | 36.5% | 39.7% | 45.6% |
|
Diluted EPS | $5.82 | $4.70 | $4.08 | $4.45 | $3.71 | $2.35 | $2.07 | $2.15 |
Shares outstanding (diluted) | 2,569.4 | 2,621.4 | 2,660.4 | 2,717.6 | 2,774.6 | 2,848.6 | 2,889.3 | 2,948.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|